Abstract:The cognitive decline associated with chronic metabolic disease diabetes has garnered extensive scrutiny, yet its pathogenesis remains incompletely understood, and the advancement of targeted therapeutics has posed a persistent challenge. Ferroptosis, a novel form of cell death characterized by intracellular lipid peroxidation and iron overload, has recently emerged as a significant factor. Numerous contemporary studies have corroborated that ferroptosis within the neurovascular unit is intimately associated with the onset of diabetes-induced cognitive impairment. Numerous contemporary studies have corroborated that ferroptosis within the neurovascular unit is intimately associated with the onset of diabetic cognitive impairment (DCI). This article initially conducts a profound analysis of the mechanism of ferroptosis, followed by a detailed elucidation of the specific manifestations of neurovascular unit ferroptosis in the context of diabetic cognitive function impairment. Furthermore, an exhaustive review of pertinent literature from April 2020 to March 2024 has been undertaken, resulting in the selection of 31 documents of significant reference value. These documents encompass studies on 11 distinct drugs, all of which are centered around investigating methods to inhibit the ferroptosis pathway as a potential treatment for DCI. Simultaneously, we conducted a review of 12 supplementary literary sources that presented 10 pharmacological agents with anti-ferroptosis properties in other neurodegenerative disorders. This article critically examines the potential influence of neurovascular unit ferroptosis on the progression of cognitive impairment in diabetes, from the three aforementioned perspectives, and organizes the existing and potential therapeutic drugs. It is our aspiration that this article will serve as a theoretical foundation for scholars in related disciplines when conceptualizing, investigating, and developing novel clinical drugs for DCI.

Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy

Ferroptosis and Renal Fibrosis: A New Target for the Future (Review)

Targeting Ferroptosis in Breast Cancer

Targeting ferroptosis: a new therapeutic opportunity for kidney diseases

Ferroptosis as a potential new therapeutic target for diabetes and its complications

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Targeting ferroptosis for treating kidney disease

Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy

Ferroptosis involves in renal tubular cell death in diabetic nephropathy

Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications

The significance of ferroptosis in renal diseases and its therapeutic potential

Ferroptosis: an important player in the inflammatory response in diabetic nephropathy

Targeting Ferroptosis As a Potential Prevention and Treatmentstrategy for Human Diseases

Research progress on ferroptosis in diabetic kidney disease

Ferroptosis: A New View on the Prevention and Treatment of Diabetic Kidney Disease with Traditional Chinese Medicine

Targeting ferroptosis by natural products in pathophysiological conditions

SRS 16-86 promotes diabetic nephropathy recovery by regulating ferroptosis

Targeting ferroptosis opens new avenues for the development of novel therapeutics

Targeting ferroptosis in the neurovascular unit: A promising approach for treating diabetic cognitive impairment

Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications

Targeting Ferroptosis in Cardio‐metabolic‐diseases: Mechanisms and Therapeutic Prospects